Lexicon Pharmaceuticals Articles
Lexicon Pharma updates on clinical pipeline
21 February 2013
News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102
17 December 2012
Lexicon Pharma acquires Symphony Icon, obtaining rights to gastrointestinal drugs for up to $90 million
3 August 2010
Showing 1-3 of 3 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
